Peer, M.A.

virus infection vaccinated antibody immunodeficiency siebelink challenge vaccination vaccine autologou immunodeficiency virus envelope enhancement journal challenge infection envelope protein protein cats vaccinated study osterhau clone fiv -19k virology autologous fiv-infected cells vaccinated cats control cats fiv-infected post-challenge clone control antigen glycoprotein replication assay plasma response hosie lentiviru elisa titre activation aids research development time-point fiv-infected cells mechanism 2 weeks post-challenge fiv -19k proviral dna immunodeficiency virus vaccination rimmelzwaan induction immunodeficiency virus infection immunology 4 weeks post-challenge blood immunity serum virus-neutralizing flynn neutralization huisman culture disease gag-specific antibodies virus-neutralizing antibodies 10 cid peptide centre test virus loads crfk cells immune-stimulating complexes fivdp virus replication receptor antigen elisa antigen production viraemia protection montelaro virus load